Question 1

What are the potential benefits of combining docetaxel with enzalutamide compared to docetaxel alone?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Docetaxel Alone or in Combination With Enzalutamide for mCRPC Previously Treated With Abiraterone at mHSPC Stage clinical trial (NCT05627752). Contact the study team or your healthcare provider for specific answers.

Question 2

What side effects should I expect from this treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Docetaxel Alone or in Combination With Enzalutamide for mCRPC Previously Treated With Abiraterone at mHSPC Stage clinical trial (NCT05627752). Contact the study team or your healthcare provider for specific answers.

Question 3

How will my progress be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Docetaxel Alone or in Combination With Enzalutamide for mCRPC Previously Treated With Abiraterone at mHSPC Stage clinical trial (NCT05627752). Contact the study team or your healthcare provider for specific answers.

Question 4

What happens if I experience severe side effects?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Docetaxel Alone or in Combination With Enzalutamide for mCRPC Previously Treated With Abiraterone at mHSPC Stage clinical trial (NCT05627752). Contact the study team or your healthcare provider for specific answers.

Question 5

Are there any travel requirements for participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Docetaxel Alone or in Combination With Enzalutamide for mCRPC Previously Treated With Abiraterone at mHSPC Stage clinical trial (NCT05627752). Contact the study team or your healthcare provider for specific answers.

Question 6

How will this trial fit with my current treatment plan?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Docetaxel Alone or in Combination With Enzalutamide for mCRPC Previously Treated With Abiraterone at mHSPC Stage clinical trial (NCT05627752). Contact the study team or your healthcare provider for specific answers.

What this study is about